Camrese Lo extended-cycle and Hyaluronidase and rituximab
Determining the interaction of Camrese Lo extended-cycle and Hyaluronidase and rituximab and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: ethinyl estradiol / levonorgestrel
Brand name: Amethia, Amethia Lo, Camrese, Camrese Lo, Daysee, Introvale, Jolessa, LoSeasonique, Quartette, Quasense, Seasonale, Seasonique, Afirmelle, Altavera, Amethyst, Ashlyna, Aubra, Aubra EQ, Aviane, Ayuna, Balcoltra, Chateal, Chateal EQ, Delyla, Enpresse-28, FaLessa, Falmina, Fayosim, Kurvelo, Larissia, Lessina, Levonest, Levora 015/30, Lillow, Lutera, Marlissa, Myzilra, Orsythia, Portia-28, Rivelsa, Setlakin, Simpesse, Sronyx, Trivora, Vienva, Alesse, Enpresse, Levlen, Levora, Lybrel, Nordette, Portia, Tri-Levlen, Triphasil-21, Triphasil-28, Trivora-28, Preven EC, Triphasil
Synonyms: Camrese Lo (extended-cycle), Camrese Lo
Generic Name: hyaluronidase / rituximab
Brand name: Rituxan Hycela
Synonyms: Rituximab and Hyaluronidase
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Camrese Lo extended-cycle-Hyaluronidase and trastuzumab
- Camrese Lo extended-cycle-Hyaluronidase injection
- Camrese Lo extended-cycle-Hyaluronidase Injection (Human)
- Camrese Lo extended-cycle-Hyaluronidase Subcutaneous, Injection
- Camrese Lo extended-cycle-Hyate:C
- Camrese Lo extended-cycle-Hybrisil
- Hyaluronidase and rituximab-Canagliflozin
- Hyaluronidase and rituximab-Canagliflozin and metformin
- Hyaluronidase and rituximab-Canagliflozin and Metformin Extended-Release Tablets
- Hyaluronidase and rituximab-Canagliflozin and Metformin Tablets
- Hyaluronidase and rituximab-Canakinumab
- Hyaluronidase and rituximab-Canakinumab Subcutaneous